Zymeworks Inc. (ZYME)

NASDAQ

$26.51

$+0.93

(+3.64%)

Regular Market

Zymeworks Inc. (ZYME) Live Price Chart

Last updated: ⁦2026-10-20 14:34:20⁩. Prices reflect the latest regular market data. Stock price data is sourced from Massive.

Summary

Zymeworks Inc. (ZYME) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $26.51, with a market capitalization of $1.80B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $16.00 to $31.34. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$1.80B
Open	$25.76
Day's High	$59.03
Day's Low	$4.11
Previous Close	$25.54
Volume	72.63K
Average Volume	811.96K
P/E Ratio	--
52-Week High	$31.34
52-Week Low	$16.00
Dividend Yield	--
Earnings Date	--

Zymeworks Inc. (ZYME) Stock Price Today

Zymeworks Inc. (ZYME) is currently trading at $26.51 as of 2026-10-20 14:33:00, up 3.79% ($0.97) from the previous close of $25.54

During today's regular trading session, ZYME has traded between $4.11 and $59.03, with a trading volume of 72.63K shares. The current price is near the middle of today's range.

Zymeworks Inc. (ZYME) 7-Day Stock Price Change

Over the past seven days, Zymeworks Inc. (ZYME) moved from $25.79 to $26.51, representing a gain of 2.79% ($0.72).

The stock traded between $24.60 and $26.65 during the period. The latest price is near the upper end of the 7-day range, indicating moderate upward.

The average daily volume was 1.39 million shares, up versus the previous seven-day period, indicating higher trading activity.

ZYME 52-Week Price Position

Position in Range: 68.5%

52W Low$16.00

52W High$31.34

ZYME is currently trading at $26.51, placing it 68.5% of the way from its 52-week low of $16.00 to its 52-week high of $31.34. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Zymeworks Inc. (ZYME)?

Zymeworks Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development and commercialization of next-generation multifunctional biotherapeutics. Its suite of therapeutic platforms and its fully integrated drug development engine enables precise engineering of differentiated therapeutic product candidates. Its clinical candidate, zanidatamab, is a novel HER2-targeted bispecific antibody currently being evaluated in multiple Phase 1, Phase 2, and pivotal clinical trials globally as a targeted treatment option for patients with solid tumors that express HER2. It is also advancing a deep preclinical pipeline in oncology and other therapeutic areas.

Zymeworks Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	264
Exchange	NASDAQ
Company Website	https://www.zymeworks.com

How to Buy Zymeworks Inc. (ZYME) Stock on MEXC

Eligible investors can buy real shares of Zymeworks Inc. (ZYME) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for ZYME and Place Your Order

Open the RealStocks trading page and search for ZYME. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Zymeworks Inc. (ZYME) stock price today?

Zymeworks Inc. (ZYME) is currently trading at $ 26.51, up 3.79% ($0.97) from the previous close of $ 25.54. Intraday prices update in real time during regular trading hours.

2.Is ZYME stock going up or down today?

As of 2026-10-20 14:33:00, ZYME is trading at $ 26.51, up 3.79% ($0.97) from its previous close of $ 25.54. The stock has traded between $ 4.11 and $ 59.03 during today’s regular session. Past price movements do not guarantee future results.

3.What is ZYME pre-market price?

As of 2026-10-20 14:33:00, ZYME is trading at $ 25.44 in pre-market trading, down 0.41% ($0.11) from the previous close of $ 25.54. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is ZYME after-hours price?

As of 2026-10-20 14:33:00, ZYME is trading at $ 25.55 in after-hours trading, up 0.02% ($0.01) from the regular-session close of $ 25.54. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is ZYME stock trading now?

ZYME trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does ZYME sit relative to its 52-week high and low?

Over the past 52 weeks, ZYME has traded between a low of $ 16.00 and a high of $ 31.34. At $ 26.51, the stock is positioned 68.5% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Zymeworks Inc. in?

Zymeworks Inc. (ZYME) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Zymeworks Inc.'s market capitalization and where is it listed?

Zymeworks Inc. is listed on the NASDAQ exchange with a market capitalization of $ 1.80B. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is ZYME valued in terms of P/E ratio and EPS?

ZYME trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -2.09. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Zymeworks Inc. pay a dividend?

Zymeworks Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.